Melanoma/Skin Cancer News

Patients with persistent melanoma in situ have shown tumor clearance with imiquimod after surgery, according to a study.

Staffing shortages at radiation oncology clinics are causing treatment delays and increased patient anxiety, according to results of a national survey from American Society for Radiation Oncology.

A combination of imiquimod 5% cream, 5-fluorouracil 2% solution and tretinoin 0.1% cream may be an effective chemoprevention option for reducing the incidences of keratinocyte carcinomas for at least 1 year, according to a study.

Topical DNA repair enzymes did not participate in the recovery of damaged skin, characterized by altered genes, following ultraviolet light exposure, according to a study.

Topical photodynamic therapy and methyl aminolevulinate, marketed as Metvix, displayed effectiveness and good cosmetic outcomes in the treatment of basal cell carcinomas following surgery, according to a study.

The integration of convolutional neural networks into dermatology practices, especially those with fewer than 5 years of experience, may increase diagnostic accuracy of skin cancer, according to a prospective study.

Primary endpoints of randomized clinical trials for cancer therapies frequently change after trial initiation, according to findings published in JAMA Network Open.

Although skin cancer is the most common type of cancer worldwide, melanoma — the deadliest form of skin cancer — has a 5-year survival rate of 99% when detected early.

Wide local excision and Mohs micrographic surgery exhibited no difference in survival outcomes among patients with Merkel cell carcinoma, according to a study.

Telemedicine garnered higher satisfaction ratings than in-person visits among patients with cancer in terms of access and care provider concern, according to a study published in Journal of the National Comprehensive Cancer Network.